CGuard™ EPS is an investigational device in USA

The CGuard^TM Embolic Prevention System (EPS) is a novel mesh carotid stent designed to improve patient safety through sustained embolic protection.^1,2

What makes CGuard^TM  (EPS) unique?

Dual Layer Design Combines the largest open-cell frame of available carotid stents with the smallest mesh pore size3 MicroNet™® Prevents plaque Protrusion through the stent, for lasting embolic protection demonstrated for up to 48 months1 SmartFitTM technology Eliminates the need for tapered version and supports accurate vessel wall apposition2,3

CGuard^TM EPS is designed to reduce the risk of both early and late embolism⁴

CGuard^TM EPS is designed to prevent peri-procedural and late embolisation by trapping potential emboli against the arterial wall while maintaining perfusion to the external carotid artery.^2,4

Data from the PARADIGM-Extend study in patients with symptomatic or increased-stroke-risk asymptomatic carotid stenosis demonstrate sustained embolic protection with CGuard^TM EPS over a 48-month follow-up period:¹

See how CGuard^TM EPS is deployed

The rapid exchange (Rx) system delivers the self-expanding CGuard^TM EPS to the carotid artery where it adapts to the vessel diameter, eliminating the need for a tapered design.^2,3

CGuard^TM EPS in action

InspireMD has established CGuard^TM Centers of Excellence at leading hospitals in Europe to help educate and share experiences with CGuard^TM through workshops and live cases.

Watch case studies of CGuard^TM EPS implantation performed at our Centers of Excellence.

Product Details:

• Indications: The CGuard^TM EPS is indicated for improving carotid luminal diameter in patients at high risk for adverse events from carotid endarterectomy who require carotid revascularisation and meet both the following criteria: Patients with neurological symptoms and >50% stenosis of the common or internal carotid artery by either ultrasound or angiogram OR patients without neurological symptoms and >80% stenosis of the common or internal carotid artery by either ultrasound or angiogram; and patients having a vessel with reference diameters between 4.8 mm and 9.0 mm at the target lesion.⁵
• CGuard^TM material: Nitinol
• MicroNet™^® material: Polyethylene Terephthalate (PET)

*60mm sizes are not available in Australia

Contact Us

CGuard^TM EPS is an investigational device in USA. 

References: 1. Musialek P et al. PARADIGM-Extend Prospective Academic Trial: Accumulating long-term evidence for MicroNet™-covered stent safety and stroke prevention efficacy. Presentation at ESC Congress 2019, Paris, France, 31 August 2019 to 4 September 2019. 2. Wissgott C et al. J Endovasc Ther 2017;24(1):130–137. 3. Musialek P, Hopkins LN, Siddiqui AH. Postepy Kardiol Interwencyjnej 2017;13(2):95–106. 4. Schofer J et al. JACC Cardiovasc Interv 2015;17(8):1229–1234. 5. CGuard™ Instructions for Use.